Article (Scientific journals)
Reply to Orlhac, F.; Buvat, I. Comment on "Ibrahim et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. Cancers 2021, 13, 1848".
Ibrahim, Abdalla; Refaee, Turkey; Primakov, Sergey et al.
2021In Cancers, 13 (12), p. 3080
Peer Reviewed verified by ORBi
 

Files


Full Text
Reply to Orlhac.pdf
Author postprint (549.76 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Oncology; Cancer Research
Abstract :
[en] We would like to thank Orlhac and Buvat [...].
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Ibrahim, Abdalla ;  The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 Maastricht, The Netherlands ; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 Maastricht, The Netherlands ; Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, University Hospital of Liège and GIGA CRC-In Vivo Imaging, University of Liège, 4000 Liege, Belgium ; Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA), University Hospital RWTH Aachen University, 52074 Aachen, Germany
Refaee, Turkey ;  The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 Maastricht, The Netherlands ; Department of Diagnostic Radiology, Faculty of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia
Primakov, Sergey ;  The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 Maastricht, The Netherlands ; Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA), University Hospital RWTH Aachen University, 52074 Aachen, Germany
Barufaldi, Bruno;  Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Acciavatti, Raymond J ;  Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Granzier, Renée W Y ;  Department of Surgery, GROW-School for Oncology, Maastricht University Medical Centre+, 6200 Maastricht, The Netherlands
HUSTINX, Roland  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Mottaghy, Felix M;  Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 Maastricht, The Netherlands ; Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA), University Hospital RWTH Aachen University, 52074 Aachen, Germany
Woodruff, Henry C ;  The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 Maastricht, The Netherlands ; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 Maastricht, The Netherlands
Wildberger, Joachim E;  Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 Maastricht, The Netherlands
Lambin, Philippe  ;  Université de Liège - ULiège > Département des sciences cliniques ; The D-Lab, Department of Precision Medicine, GROW-School for Oncology, Maastricht University, 6200 Maastricht, The Netherlands ; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, 6200 Maastricht, The Netherlands
Maidment, Andrew D A ;  Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Language :
English
Title :
Reply to Orlhac, F.; Buvat, I. Comment on "Ibrahim et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. Cancers 2021, 13, 1848".
Publication date :
21 June 2021
Journal title :
Cancers
eISSN :
2072-6694
Publisher :
MDPI AG, Switzerland
Volume :
13
Issue :
12
Pages :
3080
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
Conflicts of Interest: Philippe Lambin reports, within and outside the submitted work, grants/sponsored research agreements from radiomics SA, ptTheragnostic/DNAmito, Health Innovation Ventures. He received an advisor/presenter fee and/or reimbursement of travel costs/consultancy fee and/or in kind manpower contribution from Radiomics SA, BHV, Merck, Varian, Elekta, ptTheragnostic, BMS and Convert pharmaceuticals. Dr Lambin has minority shares in the company Radiomics SA, Convert Pharmaceuticals, MedC2, and LivingMed Biotech, he is the co-inventor of two issued patents with royalties on radiomics (PCT/NL2014/050248, PCT/NL2014/050728) licensed to Radiomics SA, one issued patent on mtDNA (PCT/EP2014/059089) licensed to ptTheragnostic/DNAmito, three non-patented inventions (softwares) licensed to ptTheragnostic/DNAmito, Radiomics SA, and Health Innovation Ventures, and three non-issued, non-licensed patents on deep learning radiomics and LSRT (N2024482, N2024889, N2024889). He confirms that none of the above entities or funding were involved in the preparation of this paper. Woodruff has minority shares in the company Onco-Radiomics. Mottaghy received an advisor fee and reimbursement of travel costs from Oncoradiomics. He reports institutional grants from GE and Nanomab outside the submitted work. Wildberger reports institutional grants from Agfa, Bard, Bayer, GE, Optimed, Philips, Siemens, and personal fees (Speaker’s Bureau) from Bayer and Siemens outside the submitted work. The rest of the co-authors declare no competing interests.Funding: Authors acknowledge financial support from ERC advanced grant (ERC-ADG-2015 n◦ 694812-Hypoximmuno). Authors also acknowledge financial support from the European Union’s Horizon 2020 research and innovation programme under grant agreement: ImmunoSABR n◦ 733008, MSCA-ITN-PREDICT n◦ 766276, CHAIMELEON n◦ 952172, EuCanImage n◦ 952103, TRANSCAN Joint Transnational Call 2016 (JTC2016 CLEARLY n◦ UM 2017-8295). Authors further acknowledge financial support by the Dutch Cancer Society (KWF Kankerbestrijding), project no. 12085/2018-2, and Maastricht-Liege Imaging Valley grant, project no. “DEEP-NUCLE”.Authors acknowledge financial support from ERC advanced grant (ERC-ADG-2015 n? 694812-Hypoximmuno). Authors also acknowledge financial support from the European Union?s Horizon 2020 research and innovation programme under grant agreement: ImmunoSABR n? 733008, MSCA-ITN-PREDICT n? 766276, CHAIMELEON n? 952172, EuCanImage n? 952103, TRANSCAN Joint Transnational Call 2016 (JTC2016 CLEARLY n? UM 2017-8295). Authors further acknowledge financial support by the Dutch Cancer Society (KWF Kankerbestrijding), project no. 12085/2018-2, and Maastricht-Liege Imaging Valley grant, project no. ?DEEP-NUCLE?.
Available on ORBi :
since 15 March 2022

Statistics


Number of views
109 (0 by ULiège)
Number of downloads
103 (0 by ULiège)

Scopus citations®
 
7
Scopus citations®
without self-citations
2
OpenCitations
 
4

Bibliography


Similar publications



Contact ORBi